Transplant Surgery »  Meet the Team »  Endocrinology »  Umesh Masharani, M.B., M.D.

Umesh Masharani, M.B., M.D.

Clinical Professor of Medicine
Division of Endocrinology
Department of Medicine

Contact Information

Endocrinology/Metabolism
400 Parnassus Ave.
ACC 585, Box 1222
San Francisco, CA 94143
umeshm@medicine.ucsf.edu

All Clinic Information

Open Popup
  • Middlesex Medical School, London 1982
  • Birmingham Teaching Hospital, United Kingdom, Internal Medicine 1985
  • UCSF Medical Center, Endocrinology/Metabolism 1993
  • American Board of Internal Medicine - Primary Certificate
  • American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism - Subspecialty
  • Diabetes Center
  • UCSF Kidney Transplant Program
  • Adrenal Insufficiency
  • Cushings Disease
  • Pheochromocytoma
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Hypoglycemic Agents
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length

Dr. Masharani is a Clinical Professor of Endocrinology and Metabolism in the Department of Medicine, UCSF. He has an active clinical practice treating patients with diabetes and other endocrine disorders. . As a member of the UCSF Islet Transplant Group, Dr Masharani assists in managing diabetes of patients admitted to UCSF for islet transplantation evaluation.

Dr. Masharani is Co-Chair of the University of California, San Francisco Diabetes Teaching Center Annual Patient Symposium. Dr. Masharani is the author of Diabetes Demystified, a complete guide to understanding and managing diabetes.

Dr. Masharani is a Co-Investigator on a number of NIH funded diabetes studies at UCSF. His research includes studies evaluating the effect of chromium and alpha lipoic acid on insulin resistance, and anti-CD3 antibodies on new onset type 1 diabetes and multi-ethnic studies addressing the interactive relationships among disease management, glucose control and depression in patients with type 2 diabetes.

Most recent publications from a total of 51
  1. Fisher L, Hessler D, Polonsky W, Strycker L, Masharani U, Peters A. Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. J Diabetes Complications. 2016 Aug; 30(6):1123-8. View in PubMed
  2. Bailey K, Yazdi T, Masharani U, Tyrrell B, Butch A, Schaufele F. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs. PLoS One. 2016; 11(3):e0151860. View in PubMed
  3. Moassesfar S, Masharani U, Frassetto LA, Szot GL, Tavakol M, Stock PG, Posselt AM. A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes. Am J Transplant. 2016 Feb; 16(2):518-26. View in PubMed
  4. Fisher L, Hessler DM, Polonsky WH, Masharani U, Peters AL, Blumer I, Strycker LA. Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis. Diabet Med. 2015 Oct 3. View in PubMed
  5. Masharani U, Sherchan P, Schloetter M, Stratford S, Xiao A, Sebastian A, Nolte Kennedy M, Frassetto L. Metabolic and physiologic effects from consuming a hunter-gatherer (Paleolithic)-type diet in type 2 diabetes. Eur J Clin Nutr. 2015 Aug; 69(8):944-8. View in PubMed
  6. Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, Strycker LA, Bowyer V. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015 May-Jun; 29(4):572-7. View in PubMed
  7. Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, Frassetto L, Petersen RC, Miller BL, Goetzl EJ. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. FASEB J. 2015 Feb; 29(2):589-96. View in PubMed
  8. Chandran S, Masharani U, Webber AB, Wojciechowski DM. Prediabetic living kidney donors have preserved kidney function at 10 years after donation. Transplantation. 2014 Apr 15; 97(7):748-54. View in PubMed
  9. Fisher L, Hessler D, Masharani U, Strycker L. Impact of baseline patient characteristics on interventions to reduce diabetes distress: the role of personal conscientiousness and diabetes self-efficacy. Diabet Med. 2014 Jun; 31(6):739-46. View in PubMed
  10. Hessler D, Fisher L, Glasgow RE, Strycker LA, Dickinson LM, Arean PA, Masharani U. Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care. 2014; 37(3):617-24. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Umesh Masharani, M.B., M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X